Alltracel reports upbeat 2003 results

Irish pharmaceutical firm Alltracel has released much improved 2003 results with full year revenue up 61% to €1.01m.

The company, which is listed on the alternative investment market (AIM) in London, said it's loss for last year was €2.6m, compared to €3m in 2002.